The Scientific Advisory Board plays a major role in the process for reviewing and selecting ELIXIR Nodes and provides strategic scientific advice to the ELIXIR Board. The SAB is an independent body, made up of leading experts from around the world. The committee also includes two independent ethics advisors to advise on ethical, legal and social issues related to ELIXIR. The ELIXIR SAB meets twice a year.
What the SAB does
- Reviews applications for new Nodes and makes recommendations to the ELIXIR Board
- Ensures scientific and technical excellence and relevance (including independent quality assurance)
- Identifies and recommends emerging challenges and opportunities, both within and beyond ELIXIR activities (including specific periodic reviews)
- Carries out periodic scientific reviews of ELIXIR Platforms and Use Cases
- Reports directly to the ELIXIR Board and ELIXIR Director on the results of their scientific reviews of ELIXIR activities
SAB members
- Chair: Dr Doreen Ware
- Vice-Chair: Prof. Philip Bourne
Name | Affiliation |
---|---|
Prof. Philip Bourne (Vice-Chair) | University of Virginia, USA |
Prof. Ana Sofia Carvalho | Catholic University of Portugal, Portugal |
Dr Jennifer Gardy | Bill & Melinda Gates Foundation, USA |
Dr Robert Gentleman | Harvard Medical School, USA |
Prof. Melissa Haendel | Oregon Health and Science University, USA |
Prof. Elina Ikonen | University of Helsinki, Finland |
Dr Janet Kelso | Max Planck Institute for Evolutionary Anthropology, Germany |
Prof. Nicola Mulder | UCT Computational Biology Group (NBN), South Africa |
Dr BF Francis Ouellette | Neuro Bioinformatics Core & Tannenbaum Open Science Institute, Canada |
Dr Augusto Rendon | Genomics England, UK |
Dr Susan E. Wallace | University of Leicester, UK |
Dr Doreen Ware (Chair) | USDA ARS, Cold Spring Harbor Laboratory, USA |
Members of the SAB (from left to right): Elina Ikonen, Larry Hunter, Melissa Haendel, Philip Bourne, Janet Kelso, BF Francis Ouellette, Susan Wallace, Doreen Ware, Robert Gentleman, Nicola Mulder.